The annual public report from the Joint Drug Prevention and Treatment Program’s Independent Program Administrator has been released by Major League Baseball. The stats:
- There were 5,391 total drug tests. 4,022 were urine samples, 1,369 were blood samples;
- There were eight positive tests resulting in discipline. All were for stimulants. Seven of the stimulant tests were for Adderall. One for Methylhexaneamine. I guess that means that there are no more steroids in baseball. Yay!
- There were 13 “non-analytical positives.” That’s baseball code for “Biogenesis dudes.”
- There were 122 therapeutic use exemptions for otherwise banned drugs. 119 of them were for ADD drugs like Adderall. Three were three for hypogonadism. A couple of years ago here was only one for hypogonadism, so that’s on the uptick. On the bright side, two years ago there was a therapeutic use exemption for narcolepsy and now there is none. So the narcoleptic either got better or retired.
The most interesting thing here, to me anyway, continues to be the number of Adderall-users in baseball. It’s estimated that 4.7% of the adult population has ADD. 119 of roughly 1,200 major leaguers on 40-man rosters puts the ADD rate at nearly 10%. Back that number down a little bit for the various guys that shuffle in and out of 400-man rosters and you figure that baseball players have ADD diagnosis at around twice the level of that in the normal population.
Are baseball players more likely to have ADD than the rest of the adult population? Are they just more likely to be diagnosed that way? Or are therapeutic use exemptions for ADD drugs a means of getting something ballplayers have always found beneficial — stimulants — in a legal way?
Free agent right-hander Jeff Manship has reportedly signed with the NC Dinos of the Korea Baseball Organization, according to FanRag Sports’ Jon Heyman. The righty was non-tendered by the Indians in December.
Manship, 32, completed his second season with Cleveland in 2016. He delivered a 3.12 ERA, 4.6 BB/9 and 7.5 SO/9 rate over 43 1/3 innings, a slight decline after posting an 0.92 ERA with the club the year before. During eight years in the major leagues, Manship carries a 4.82 career ERA, 3.6 BB/9 and 6.4 SO/9 in multiple stints with the Twins, Rockies, Phillies and Indians.
The right-hander will be joined by fellow MLB transplants Eric Hacker and Xavier Scruggs, each of whom took one-year deals with the Dinos last month. Steve Adams of MLB Trade Rumors notes that each KBO team is allowed up to three foreign players, so Manship will round out the trio when he joins the roster. Any salary terms have yet to be disclosed.
With the Braves on the cusp of formalizing their one-year deal with Kurt Suzuki, the market for free agent catcher Matt Wieters is dwindling. ESPN’s Jerry Crasnick references an inside source that lists the Angels, Rockies and Reds as potential suitors for the 30-year-old’s services.
Wieters is coming off of an eight-year career with the Orioles. In 2016, he played through his first full year after undergoing Tommy John surgery in 2014 and batted .243/.302/.409 with 17 home runs and a .711 OPS in 464 PA. A return to Baltimore in 2017 isn’t out of the question, Crasnick writes, citing some within the team that would be open to Wieters stepping into a DH role and catching platoon with Wellington Castillo. However, he also points out that the front office appears divided on the veteran catcher, and sees the Orioles as a long shot for the foreseeable future.
The Angels have already been tied to Wieters this offseason, while the Rockies and Reds don’t appear to have made any formal inquiries so far. Both could use a veteran presence behind the dish, as the Rockies are planning to platoon rookie catcher Tom Murphy with 24-year-old Tony Wolters in the spring. The Reds, meanwhile, are banking on a quick recovery for 28-year-old Devin Mesoraco, who missed most of the 2016 season after undergoing shoulder and hip surgery and forced the club to rely almost exclusively on back-up backstop Tucker Barnhart.